305 related articles for article (PubMed ID: 25646199)
1. The utility of inpatient rebound bilirubin levels in infants readmitted after birth hospitalization for hyperbilirubinemia.
Berkwitt A; Osborn R; Grossman M
Hosp Pediatr; 2015 Feb; 5(2):74-8. PubMed ID: 25646199
[TBL] [Abstract][Full Text] [Related]
2. Rebound in serum bilirubin level following intensive phototherapy.
Maisels MJ; Kring E
Arch Pediatr Adolesc Med; 2002 Jul; 156(7):669-72. PubMed ID: 12090833
[TBL] [Abstract][Full Text] [Related]
3. Outcome analysis of jaundice fast-track system implementation in Thammasat University Hospital.
Tanticharoenwiwat P; Techasatid W
J Med Assoc Thai; 2014 May; 97(5):500-5. PubMed ID: 25065088
[TBL] [Abstract][Full Text] [Related]
4. A Clinical Prediction Rule for Rebound Hyperbilirubinemia Following Inpatient Phototherapy.
Chang PW; Kuzniewicz MW; McCulloch CE; Newman TB
Pediatrics; 2017 Mar; 139(3):. PubMed ID: 28196932
[TBL] [Abstract][Full Text] [Related]
5. Yield of recommended blood tests for neonates requiring phototherapy for hyperbilirubinemia.
Besser I; Perry ZH; Mesner O; Zmora E; Toker A
Isr Med Assoc J; 2010 Apr; 12(4):220-4. PubMed ID: 20803881
[TBL] [Abstract][Full Text] [Related]
6. Rebound hyperbilirubinemia in term infants after phototherapy.
Al-Saedi SA
Saudi Med J; 2002 Nov; 23(11):1394-7. PubMed ID: 12506303
[TBL] [Abstract][Full Text] [Related]
7. Impact of universal bilirubin screening on severe hyperbilirubinemia and phototherapy use.
Kuzniewicz MW; Escobar GJ; Newman TB
Pediatrics; 2009 Oct; 124(4):1031-9. PubMed ID: 19786442
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors of post-phototherapy neonatal rebound hyperbilirubinemia.
Elhawary IM; Abdel Ghany EAG; Aboelhamed WA; Ibrahim SGE
World J Pediatr; 2018 Aug; 14(4):350-356. PubMed ID: 29464578
[TBL] [Abstract][Full Text] [Related]
9. Does cord blood bilirubin level help the physician in the decision of early postnatal discharge?
Ipek IO; Bozaykut A; Çağrıl SC; Sezer RG
J Matern Fetal Neonatal Med; 2012 Aug; 25(8):1375-8. PubMed ID: 22128898
[TBL] [Abstract][Full Text] [Related]
10. A comparison of alternative risk-assessment strategies for predicting significant neonatal hyperbilirubinemia in term and near-term infants.
Keren R; Luan X; Friedman S; Saddlemire S; Cnaan A; Bhutani VK
Pediatrics; 2008 Jan; 121(1):e170-9. PubMed ID: 18166536
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of discharge management in the prediction of hyperbilirubinemia: the Jerusalem experience.
Kaplan M; Bromiker R; Schimmel MS; Algur N; Hammerman C
J Pediatr; 2007 Apr; 150(4):412-7. PubMed ID: 17382121
[TBL] [Abstract][Full Text] [Related]
12. Impact of a transcutaneous bilirubinometry program on resource utilization and severe hyperbilirubinemia.
Wainer S; Parmar SM; Allegro D; Rabi Y; Lyon ME
Pediatrics; 2012 Jan; 129(1):77-86. PubMed ID: 22184646
[TBL] [Abstract][Full Text] [Related]
13. Predischarge screening for severe neonatal hyperbilirubinemia identifies infants who need phototherapy.
Bhutani VK; Stark AR; Lazzeroni LC; Poland R; Gourley GR; Kazmierczak S; Meloy L; Burgos AE; Hall JY; Stevenson DK;
J Pediatr; 2013 Mar; 162(3):477-482.e1. PubMed ID: 23043681
[TBL] [Abstract][Full Text] [Related]
14. Neonatal hyperbilirubinemia in the low-intermediate-risk category on the bilirubin nomogram.
Bromiker R; Bin-Nun A; Schimmel MS; Hammerman C; Kaplan M
Pediatrics; 2012 Sep; 130(3):e470-5. PubMed ID: 22926183
[TBL] [Abstract][Full Text] [Related]
15. Systematic follow-up of hyperbilirubinemia in neonates with a gestational age of 35 to 37 weeks.
Punaro E; Mezzacappa MA; Facchini FP
J Pediatr (Rio J); 2011; 87(4):301-6. PubMed ID: 21655685
[TBL] [Abstract][Full Text] [Related]
16. Phototherapy for neonatal nonhemolytic hyperbilirubinemia. Analysis of rebound and indications for discontinuing therapy.
Lazar L; Litwin A; Merlob P
Clin Pediatr (Phila); 1993 May; 32(5):264-7. PubMed ID: 8324969
[TBL] [Abstract][Full Text] [Related]
17. Clinical report from the pilot USA Kernicterus Registry (1992 to 2004).
Johnson L; Bhutani VK; Karp K; Sivieri EM; Shapiro SM
J Perinatol; 2009 Feb; 29 Suppl 1():S25-45. PubMed ID: 19177057
[TBL] [Abstract][Full Text] [Related]
18. Effect of Ursodeoxycholic Acid on Indirect Hyperbilirubinemia in Neonates Treated With Phototherapy.
Honar N; Ghashghaei Saadi E; Saki F; Pishva N; Shakibazad N; Hosseini Teshnizi S
J Pediatr Gastroenterol Nutr; 2016 Jan; 62(1):97-100. PubMed ID: 26020375
[TBL] [Abstract][Full Text] [Related]
19. Significant weight loss in breastfed term infants readmitted for hyperbilirubinemia.
Salas AA; Salazar J; Burgoa CV; De-Villegas CA; Quevedo V; Soliz A
BMC Pediatr; 2009 Dec; 9():82. PubMed ID: 20043852
[TBL] [Abstract][Full Text] [Related]
20. A Simpler Prediction Rule for Rebound Hyperbilirubinemia.
Chang PW; Newman TB
Pediatrics; 2019 Jul; 144(1):. PubMed ID: 31196939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
